“…Laterality of motor symptoms was not considered in light of previous work that revealed nonsignificant differences between PD patients with either left-sided or right-sided motor symptoms on numerous measures of cognitive functioning. 32 Participants were excluded from the study if they (a) displayed impaired global intellectual functioning [total score on the Mattis Dementia Rating Scale (MDRS)] 33 ; cutoff <133), 34 (b) had undergone a surgical procedure for the treatment of PD, (c) had a history of any other neurologic disorder and/or acquired brain injury, (d) presented with Parkinson-plus symptomatology (eg, myoclonus, apraxia, oculomotor abnormalities, ataxia, and/or sensory loss), (e) were on anticholinergic therapy (eg, trihexyphenidyl or benztropine), (f) were taking medications that could directly or indirectly impact cognitive functioning (eg, sedatives, anticonvulsants, and/or neuroleptics), (g) indicated prior history of polysubstance abuse, and/or (h) indicated prior history of psychiatric disorder (eg, depression) with or without medical treatment or hospitalization. Informed consent was obtained, and all procedures were approved by the institutional review board.…”